Mastodawn

Can acute glomerulonephritis be caused by medication? #glomerulonephritis #kidneydisease #kidney
... Continue to: https://youtube.com/shorts/1nrR5Yms1fU?si=D9ySrlr8tj-9BNR5

Show thread

AHAKO 6d ago

People of African ancestry have a fourfold higher risk of developing aggressive chronic kidney disease compared to Caucasians.

Reason: two variants of the APOL1 gene.
https://www.medizin.uni-muenster.de/molneph/forschung/thomas-weide/projekte/apol1-als-risikofaktor-fuer-nierenerkrankungen.html

During my trip through Ghana, I noticed the often poor water quality. One cause: galamsey—illegal gold mining (record prices).

About two-thirds of water sources are contaminated. 100% by 2030?

#PublicHealth #KidneyDisease #APOL1 #WaterQuality #EnvironmentalHealth #Mining #Galamsey #HealthEquity

Medizinische Fakultät Universität Münster

Exzellente, interdisziplinäre Forschung, qualitativ hochwertige Lehre, die strukturierte Förderung des wissenschaftlichen Nachwuchses und Gender mainstreaming sind zentrale Qualitätsmerkmale der Medizinischen Fakultät.

All Scientifical Apr 9

Surgical intervention for kidney infections #kidneydisease #kidneyhealth #surgery #infection ... Continue to: https://www.youtube.com/watch?v=9Oa7lGYYVpc

All Scientifical Apr 9

Do you feel pain when kidney stones pass? #kidneystone #kidneydisease #urinarysystem #kidney
... Continue to: https://youtube.com/shorts/xhHxqxEyPkA?si=UFM62tdSOtmGeB9A

All Scientifical Apr 9

🚽 Which of these is a symptom of kidney disease? #kidneyhealth #nephrology #kidneydisease ... Continue to: https://www.youtube.com/watch?v=OJPZPGVxSKI

Industry Examiner Apr 7

Why did Biogen pay up for Apellis Pharmaceuticals?

Because this may be less about buying a drug and more about buying a nephrology platform.

Our latest argues that kidney disease is starting to look like biotech’s next strategic battleground, and that Biogen’s Apellis deal may be an early signal of where the industry is heading.

#Biotech #KidneyDisease #Nephrology #Biogen #TechNews

Biogen’s $5.6 Billion Apellis Deal Is Really a Bet on Kidney Disease - Biotech Industry Examiner

The acquisition gives Biogen near-term revenue, but the more important prize may be something pharma rarely gets to buy fully formed: a nephrology commercial

Biotech Industry Examiner

All Scientifical Apr 4

Treatment of acute glomerulonephritis #kidneydisease #glomerulonephritis #kidney #nephritis
... Continue to: https://youtube.com/shorts/y9CIqq-BBNQ?si=SQXACST06MJgsGSi